T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 1, 2015 at 4pm EST
Fund Composition
Asset Allocation
as of 05/31/2016
Domestic Stock 94.4%
Foreign Stock 3.7%
Cash 1.3%
Convertibles 0.6%
Other 0.1%
Foreign Bonds 0.0%
Preferreds 0.0%
Options -0.1%
Volatility and Other Measures
as of 05/31/2016
Beta 0.93
0.37
Standard Deviation 16.93
Price/Earnings Ratio (Domestic) 18.7
Earnings Growth Rate (Domestic) 12.4
Turnover Rate 8.1
Median Market
Capitalization
$33,804.64 Million
Sector Diversification
as of 05/31/2016
% of Total Net Assets
Services 35.2%
Biotechnology 26.6%
Pharmaceuticals 19.3%
Products & Devices 11.0%
Life Sciences 6.7%
10 Largest Holdings
Represents 36.35 % of Total Net Assets
View Holdings as of:
Aetna
Alexion Pharmaceuticals
Allergan
Becton, Dickinson & Company
Bristol-Myers Squibb
Cigna
Humana
McKesson
Thermo Fisher Scientific
UnitedHealth Group
As of 05/31/2016 the Health Sciences Fund had a total of 141 holdings.
See Glossary for additional details on all data elements.